Tactile Systems Technology Inc TCMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $13.90
- Day Range
- $14.28–15.24
- 52-Week Range
- $9.70–16.95
- Bid/Ask
- $5.76 / $15.49
- Market Cap
- $343.92 Mil
- Volume/Avg
- 164,369 / 202,332
Key Statistics
- Price/Earnings (Normalized)
- 26.37
- Price/Sales
- 1.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 992
- Website
- https://www.tactilemedical.com
Comparables
Valuation
|
Metric
|
TCMD
|
NARI
|
INSP
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.37 | 437.05 | 1,150.56 |
Price/Book Value | 1.71 | 5.58 | 9.67 |
Price/Sales | 1.23 | 4.29 | 8.67 |
Price/Cash Flow | 14.55 | 327.96 | 58.08 |
Price/Earnings
TCMD
NARI
INSP
Financial Strength
|
Metric
|
TCMD
|
NARI
|
INSP
|
|---|---|---|---|
Quick Ratio | 3.77 | 1.38 | 7.91 |
Current Ratio | 4.44 | 1.80 | 9.25 |
Interest Coverage | — | −164.83 | — |
Quick Ratio
TCMD
NARI
INSP
Profitability
|
Metric
|
TCMD
|
NARI
|
INSP
|
|---|---|---|---|
Return on Assets (Normalized) | 11.66% | −1.37% | 11.56% |
Return on Equity (Normalized) | 17.56% | −1.89% | 13.47% |
Return on Invested Capital (Normalized) | 13.44% | −3.24% | 10.19% |
Return on Assets
TCMD
NARI
INSP
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Xtsgtwyn | Mltcz | $196.1 Bil | |||
| Stryker Corp
SYK
| Ngdxwdbwx | Pgbs | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Nvhyhrknx | Syrwbk | $122.3 Bil | |||
| Medtronic PLC
MDT
| Bnyfnzlh | Nlzdjy | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Ffwcprsnsc | Kcjbzc | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Svjz | Kgsk | $29.1 Bil | |||
| DexCom Inc
DXCM
| Shtqghdzv | Qrjs | $27.1 Bil | |||
| Steris PLC
STE
| Bbyhtlg | Tkltth | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Tnmdwhplh | Cpcs | $21.9 Bil | |||
| Insulet Corp
PODD
| Jxlqsrcshw | Vvjsqg | $16.5 Bil |
United States